author-photo

Diego Malón

17

Papers

84

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PS7-35: Geicam/2014-03 (registem): A prospective registry of advanced breast cancer: A subset of triple negative breast cancer patients with her2 low expression

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.

2021 Pharmacogenomics and Personalized Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports.

2020 World Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (3)
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: results from the Compassionate Use Program in Spain (PALBOCOMP)

2020 The Breast
Show All
- Source
- Cite
- Save
Citations (0)
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.

2020 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
Abstract OT2-07-02: CNIO-BR-009 trial: Targeting mitochondrial metabolism with ME-344 in breast cancer upon bevacizumab-induced vascular normalization: A phase 0 randomized clinical trial

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients

2018 Clinical & Translational Oncology
Show All
- Source
- Cite
- Save
Citations (20)
Phase I trial of the combination of the multikinase inhibitor nintedanib plus letrozole: A window of opportunity trial in adjuvant hormone-receptor positive breast cancer (HRPBC).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Objective evaluation of physical activity in Spanish breast cancer survivors.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)